My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Jindal Drilling & Industries standalone net profit declines 3.66% in the June 2016 quarter

Sep 14,2016

Net profit of Jindal Drilling & Industries declined 3.66% to Rs 9.48 crore in the quarter ended June 2016 as against Rs 9.84 crore during the previous quarter ended June 2015. Sales rose 11.24% to Rs 92.66 crore in the quarter ended June 2016 as against Rs 83.30 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales92.6683.3011
OPM %9.8912.74-
PBDT14.5518.68-22
PBT12.0915.01-19
NP9.489.84-4

Powered by Capital Market - Live News

Hindustan Unilever drops ex-dividend
Jun 22,2017

Meanwhile, the S&P BSE Sensex was up 132.06 points, or 0.42% at 31,415.70.

On the BSE, 12,000 shares were traded on the counter so far as against the average daily volumes of 1.32 lakh shares in the past one quarter. The stock had hit a high of Rs 1,118.80 and a low of Rs 1,105 so far during the day. The stock had hit a record high of Rs 1,128 on 21 June 2017 and a 52-week low of Rs 782.95 on 23 December 2016.

The stock had outperformed the market over the past one month till 21 June 2017, advancing 11.53% compared with the Sensexs 2.69% rise. The scrip had also outperformed the market over the past one quarter advancing 24.33% as against the Sensexs 6.1% rise. The scrip had also outperformed the market over the past one year advancing 28.85% as against the Sensexs 16.67% rise.

The large-cap company has equity capital of Rs 216.45 crore. Face value per share is Rs 1.

Before turning ex-dividend, the stock offered a dividend yield of 0.89% based on the closing price of Rs 1,123.70 yesterday, 21 June 2017.

Hindustan Unilevers net profit rose 6.2% to Rs 1183 crore on 6.8% increase in net sales to Rs 8100 crore in Q4 March 2017 over Q4 March 2016.

HUL is a leading fast moving consumer goods (FMCG) company.

Powered by Capital Market - Live News

Federal Bank gains ahead of fixing issue price for QIP
Jun 22,2017

The announcement was made after market hours yesterday, 21 June 2017.

Meanwhile, the S&P BSE Sensex was up 112.12 points or 0.36% at 31,395.76.

On the BSE, 2.16 lakh shares were traded on the counter so far as against the average daily volumes of 10.40 lakh shares in the past one quarter. The stock had hit a high of Rs 119.50 and a low of Rs 117.50 so far during the day. The stock had hit a record high of Rs 122.40 on 16 June 2017 and a 52-week low of Rs 52 on 24 June 2016.

The stock had outperformed the market over the past one month till 21 June 2017, advancing 3.96% compared with the Sensexs 2.69% rise. The stock had also outperformed the market over the past one quarter, gaining 31.59% as against the Sensexs 6.1% rise. The scrip had also outperformed the market over the past one year, surging 106.08% as against the Sensexs 16.67% rise.

The large-cap bank has equity capital of Rs 345.35 crore. Face value per share is Rs 2.

Federal Bank said that a committee meeting will be held on or after 27 June 2017 to consider the issue price of qualified institutional placement (QIP). The QIP opened on 21 June 2017 and floor price of Rs 117.04 per share has been fixed.

Federal Banks net profit surged 2400.9% to Rs 256.59 crore on 14.8% growth in total income to Rs 2598.06 crore in Q4 March 2017 over Q4 March 2016.

Federal Bank is one of the leading private sector banks in India.

Powered by Capital Market - Live News

Board of Prime Urban Development India approves acquisition of New Line Buildtech
Jun 22,2017

The Board of Prime Urban Development India at its meeting held on 21 June 2017 has agreed to acquire 58,02,925 Equity Shares of Rs. 10/- each at a premium of Rs. 60.71/- per share constituting 100% of the paid up equity share capital of New Line Buildtech (NLBPL), a Private Limited Company incorporated under the Companies Act, 1956. NLBPL will become a wholly owned subsidiary of PUDIL as and when the share acquisition/transfer process is completed.

Powered by Capital Market - Live News

Prism Cement hardens after JV completes expansion
Jun 22,2017

The announcement was made after market hours yesterday, 21 June 2017.

Meanwhile, the S&P BSE Sensex was up 121.18 points, or 0.39%, to 31,404.82. The S&P BSE Mid-Cap index was up 56.86 points, or 0.38%, to 14,907.60.

On the BSE, 11,248 shares were traded on the counter so far as against the average daily volumes of 1.02 lakh shares in the past one quarter. The stock had hit a high of Rs 121.80 and a low of Rs 119.90 so far during the day. The stock had hit a 52-week high of Rs 129.10 on 28 April 2017. The stock had hit a 52-week low of Rs 72 on 27 December 2016.

The stock had underperformed the market over the past one month till 21 June 2017, falling 2.82% compared with 2.69% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, gaining 15.77% as against Sensexs 6.1% gains. The scrip had also outperformed the market in past one year, gaining 24.51% as against Sensexs 16.67% gains.

The mid-cap company has equity capital of Rs 503.36 crore. Face value per share is Rs 10.

Prism Cement said that Sanskar Ceramic (Sanskar), a step-down joint venture of the company has successfully completed the expansion of 4.2 million square meters (MSM) per annum vitrified tiles capacity at its Dhuva plant, Morbi, Gujarat. The commercial production has commenced from 21 June 2017.

With this expansion, the company would be able to reduce outsourcing of vitrified tiles from third party sources and become more self-reliant. The capacity of Sanskar now stands at 2.3 MSM of wall tiles and 4.2 MSM of Vitrified Tiles.

The overall capacity of H & R Johnson (India), a division of Prism Cement, along-with its joint ventures and subsidiaries would stand at over 65 MSM per annum.

Prism Cements net profit declined 7.2% to Rs 70.15 crore on 2.3% rise in net sales to Rs 1418.57 crore in Q4 March 2017 over Q4 March 2016.

Prism Cement is an integrated building materials company, with a wide range of products from cement, ready-mixed concrete, tiles, bath products to kitchens. The company has three divisions, viz. Prism Cement, H & R Johnson (India) and RMC Readymix (India).

Powered by Capital Market - Live News

GRUH Finance allots 1,26,945 equity shares
Jun 22,2017

GRUH Finance has allotted 1,26,945 equity shares under ESOP. With this allotment, the paid up equity share capital of the Company stands at Rs 73.02 crore consisting 36,51,24,274 equity shares of Rs 2 each.

Powered by Capital Market - Live News

Board of Econo Trade India approves change in registered office
Jun 22,2017

Econo Trade India announced that the Board of Directors at its meeting held on 21 June 2017 has approved change in registered office to 9/12 Lal Bazaar Street, 3rd Floor, Block B, Room No. 3103, Kolkata - 700 001.

Powered by Capital Market - Live News

Nila Infrastructures secures order from Ahmedabad Municipal Corporation
Jun 22,2017

Nila Infrastructures has received work order from Ahmedabad Municipal Corporation, of slum rehabilitation and re-development for construction of 360 units on PPP basis at Ahmedabad under Urban Development & Urban Housing Department, Government of Gujarats Slum Rehabilitation and Redevelopment Policy-2013.

The Project envisages to rehabilitate about 360 slum-dwelling families living at Khodiyarnagar Asarwa, Ahmedabad. The total area under the project of approximately 6,085 sq. mtrs. will be redeveloped in 24 months at a total development cost of approximately Rs 25.16 crore. As remuneration, the Company will get the balance vacant land of approximately 1893 sq. mtrs. worth Rs 7.58 crore and the Transferable Development Rights (TDR) of Rs 17.58 crore.

Powered by Capital Market - Live News

MSP Steel & Power to hold EGM
Jun 22,2017

MSP Steel & Power announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 13 July 2017 .

Powered by Capital Market - Live News

Mewar Hi-Tech Engineering to hold board meeting
Jun 22,2017

Mewar Hi-Tech Engineering will hold a meeting of the Board of Directors of the Company on 24 June 2017.

Powered by Capital Market - Live News

Zenotech Laboratories provides update on rights issue
Jun 22,2017

Zenotech Laboratories announced that the Rights Issue Committee of the Board of Directors (the Committee) in its meeting held on 21 June 2017 has finalized the Issue opening and the Issue closing dates, including the last date of receipt of Split Application Forms with respect to the rights issue of the Company. Further, the Committee has also approved the Letter of Offer for filing with BSE and Securities and Exchange Board of India, the Abridged Letter of Offer and Composite Application Form to be sent to eligible shareholders of the Company.

Issue opens on - 30 June 2017
Last date for receiving requests for split application forms - 07 July 2017
Issue closes on - 14 July 2017

Powered by Capital Market - Live News

Alembic Pharmaceuticals receives ANDA approval for Amantadine Hydrochloride Capsules
Jun 22,2017

Alembic Pharmaceuticals has received approval from USFDA for its ANDA for Amantadine Hydrochloride Capsules, USP, 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product Symmetrel Capsules, 100 mg of Endo Pharmaceuticals Inc.

Powered by Capital Market - Live News

Shares of Riddhi Corporate Services get listed
Jun 22,2017

The equity shares of Riddhi Corporate Services (Scrip Code: 540590) are listed effective 22 June 2017 and admitted to dealings on the Exchange in the list of M Group Securities.

Powered by Capital Market - Live News

Tata Motors accelerates after committee approves fund raising
Jun 22,2017

The announcement was made after market hours yesterday, 21 June 2017.

Meanwhile, the S&P BSE Sensex was up 124.05 points or 0.4% at 31,407.69.

On the BSE, 21,247 shares were traded on the counter so far as against the average daily volumes of 5.36 lakh shares in the past one quarter. The stock had hit a high of Rs 462.70 and a low of Rs 458 so far during the day.

Tata Motors said that duly authorised committee approved offering for subscription, on a private placement basis, up to 5,000 rated, listed, unsecured, 7.50% coupon, redeemable, non-convertible debentures (NCDs) of face value Rs 10 lakh each, at par, aggregating up to Rs 500 crore.

On 15 June 2017, the company had said that it is desirous of offering the eighth series of its NCDs aggregating to Rs 500 crore and in this regard will hold a meeting of its duly constituted committee of the board on 21 June 2017.

The issuance is pursuant to the approval of the shareholders passed vide special resolution at the 71th Annual General Meeting of the company held on 9 August 2016 and the board of directors resolution passed at its meeting held on 23 May 2017.

On a consolidated basis, net profit of Tata Motors declined 16.8% to Rs 4336.43 crore on 2.9% decline in net sales to Rs 77217.19 crore in Q4 March 2017 over Q4 March 2016.

Tata Motors is a market leader in commercial vehicles in India. The companys British luxury unit Jaguar Land Rover (JLR) sells premium luxury cars.

Powered by Capital Market - Live News

Outcome of board meeting of Cerebra Integrated Technologies
Jun 22,2017

Cerebra Integrated Technologies announced that the Board of Directors at its meeting held on 22 June 2017 transacted the following -

Allotment of 1,19,00,000 Equity Shares on preferential basis to StrategicInvestor, Kuber Global Fund, a company incorporated in the Republic ofMauritius.

Allotment of 53,00,000 Warrants convertible into Equity Shares on preferential basis to certain Promoters.

Convening 23rd Annual General Meeting of the Shareholders, Book closure and related matters.

Powered by Capital Market - Live News

Glenmark Pharmaceuticals receives tentative ANDA approval for Solifenacin Succinate Tablets
Jun 22,2017

Glenmark Pharmaceuticals has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for SolifenacinSuccinate Tablets, 5 mg and 10 mg, the generic version of Vesicaren++ Tablets, 5 mg and 10 mg of Astellas Pharma US Inc.

According to IMS Health sales data for the 12 month period ending April 2017, the Vesicaren++ Tablets, 5 mg and 10 mg market achieved annual sales of approximately $1.1 billion.

Powered by Capital Market - Live News